Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
85.38 CHF | +0.31% | -1.62% | +2.14% |
Nov. 30 | NOVARTIS AG : Deutsche Bank gives a Buy rating | ZD |
Nov. 29 | NOVARTIS : Oddo BHF confirms its recommendation after R&D day | CF |
Evolution of the average Target Price on Novartis AG
Price target over the last 5 years
History : Analyst Recommendations
637abaea2004f6dc2f83de5.du5d_BJHcQXH6jeMVBJx76FkvuWknELLgZjrRoEPUHg.Dpg7lUImP0ujhmS8IFw-hfUc-a3A_TOqyvCBPPFQYz8TiWzKWHc0cbCFDw~57e0ad78ff62acfb91bf7663be23df26
More recommendations
Analysts' Consensus
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
98.09USD
Average target price
105.39USD
Spread / Average Target
+7.45%
High Price Target
124.68USD
Spread / Highest target
+27.11%
Low Price Target
83.80USD
Spread / Lowest Target
-14.56%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Novartis AG
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
BARCLAYS | Emily Field |
UBS | Colin White |
JEFFERIES | Peter Welford |
Kepler Capital Markets | |
Societe Generale | |
alphavalue | Abhishek Raval |
BERENBERG | Kerry Holford |
Redburn | |
Stifel Nicolaus | |
DZ Bank | |
JPMORGAN | Richard Vosser |
BNP Paribas | |
MORGAN STANLEY | Mark Purcell |
Barrington Research | |
Credit Suisse | |
International Strategy & Investment Group | |
Morningstar | |
ODDO BHF | |
GOLDMAN SACHS | Keyur Parekh |
DA Davidson | |
Zacks Equity Research | |
Bank of America Securities/Merrill Lynch | |
BERNSTEIN RESEARCH | Wimal Kapadia |
Kepler Cheuvreux | |
Wolfe Research | |
AltaCorp Capital | |
DEUTSCHE BANK | Emmanuel Papadakis |
HSBC | |
Exane BNP Paribas | |
Bryan, Garnier & Co. | |
Berenberg Bank | |
Deutsche Bank Securities | |
Moody's Investors Service | |
Dundee | |
Exane BNP | |
Bernstein | |
Argus | |
Cowen | |
BRYAN GARNIER | Eric Le Berrigaud |
LIBERUM CAPITAL | Graham Doyle |
BANK OF AMERICA (BOFA) | Graham Parry |
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
EPS Revisions
- Stock
- Equities
- Stock Novartis AG - Swiss Exchange
- Consensus Novartis AG